History

Committed to transforming EEG.

We founded CortiCare as a tele-EEG diagnostic company with a simple premise: to help clinicians determine real-brain functionality and abnormality in a timely and cost-effective manner. Along the way, we've helped redefine neuro-critical care, expanded the use of in-home ambulatory EEG and provided support for clinical trials.


2012
CortiCare is awarded a portion of the NEOLEV2 drug dosage study awarded to UCSD to monitor up to 300 patients at 5 different hospitals over 3 years.
2013
CortiCare monitors its first patient with just a handful of technologists, and quickly expanded to 10 hospitals served.
2014
CortiCare grows to more than 30 technologists, averaging 10+ years of experience, many who have earned their CLTM.
2015
CortiCare hires its first team of neurophysiologists to provide expert reading services and retains its first contract for reading with a teaching hospital. CortiCare begins monitoring in its first EMU (Epilepsy Monitoring Unit).
2016
CortiCare partners with several well-known institutions, including UCLA and Emory, to provide EEG reading to multiple hospitals nationwide.
2017
CortiCare hires an EU manager and provides EEG monitoring to its first dog in the UK. CortiCare grows to nearly 40 technologists.
2018
CortiCare awarded a pilot program by the Minister of Health for Hospital Affairs in Saudi Arabia to demonstrate effectiveness of ICU brain monitoring services. As a result of this successful pilot, CortiCare is now in negotiations with one of the largest hospitals in Riyadh, Saudi Arabia to provide our real-time brain monitoring services.
2019
CortiCare expands its services to provide remotely monitored, in-home ambulatory video-EEG studies with the acquisition of Physicians Ancillary Services with operations in of the US and a focus on providing the best service in the industry. CortiCare continues to grow its Pharma Clinical Trials services, working with sponsors or CROs to deliver safety EEG monitoring and interpretation.

Leadership

Management


BRAD WESTCOTT
President, CEO, Founder of CortiCare

Grew previous neuro-diagnostic company from $1M to over $30 million, including acquisitions both in US and abroad, and ending in a successful exit. He has served as CFO to another start-up in the medical space.

TIM INNES, MBA
EVP Business Development

Former director of business development at Massimo, he has over 20 years of experience with medical device startups dealing with non- invasive patient monitoring technologies. He has put together strategic partnerships, technology transfers, sales, and marketing programs.

CARL TYLER
VP Sales

A founder of PAS, one of the largest companies offering in-home Ambulatory Video-EEG services, and a seasoned sales management professional, Carl oversees the US sales team. With a focus on serving the customer and providing the best

ARON STERN, BS, MBA
Chief Financial Officer

Stern has held CFO and VP Finance positions with several companies in the healthcare market including most recently, Immutrix & Intrinsic Materials. In addition to his financial management background, he has managed IT infrastructure for public and private companies..

DR. ERIC ANDERSON, MD, PhD
Medical Director

Dr. Anderson obtained both his M.D. and Ph.D. at the University of Nebraska Medical Center. He completed his fellowship in clinical neurophysiology with a sub specialization in epilepsy at Emory University. He is widely licensed and credentialed and currently practices telemedicine in 25 states and over 80 hospitals.

STACI WESTCOTT
Director of Clinical Operations

Previous Operations Manager for Nuehealth, patient relationship SAAS connecting patients with providers. Previous customer service manager at Alpine Biomed, neuro-based diagnostic products.

DIANE LIESEN, R. EEG/EP T., CLTM
QA Manager

She also serves as the Program Director for the Neurodiagnostic Program at Lincoln Land College. She was the Clinical Coordinator and Staff Technologist for EEG programs at hospitals in both Colorado and Illinois. Past board member of both ASET and ABRET, including the executive committees.

JEFF KUZNIA, BA, RRT, RPFT
Director of Marketing

Former VP of Marketing for Compumedics USA, Inc. with over 30 years’ experience in product management, marketing, sales, and sales and marketing management in cardiopulmonary and neurology focused capital equipment and services businesses, including management of a sleep study services business.

CHRISTINE SCOTT BLODGETT, MA, R. EEG/EP T, CLTM, FASET
Senior Clinical Director

With 20 years’ experience in neurodiagnostics, she is the former Chief Technologist at Massachusetts General Hospital.  She serves as Adjunct Faculty in the Neurodiagnostic Technology program at Labouré College and is the current chairperson of the Research Committee for ASET- the Neurodiagnostic Society.

SHAWN COX, MBA, R.EEG T.
Director, Outpatient Clinical Services

Former Senior Manager at several neurodiagnostic services companies, with experience managing a diverse and remotely located operations team.  He has previously held served as the Infection Control Officer and successfully navigated a team to achieve accreditation by The Joint Commission.


Board of Directors


BRAD WESTCOTT
President and Chairman

Founded CortiCare in 2012, after he grew a previous neuro-diagnostic company from $1M to over $30 million, including acquisitions both in US and abroad, and ending in a successful exit. He has served as CFO to another start-up in the medical space.

DR. MARC NUWER, MD

Corporate Board Member, Chief, Clinical Neurophysiology UCLA, Neurology Professor. Graduated from Stanford School of Medicine. Past Board Member American Academy of Neurology (AAN) and President of the Int’l Federation of Clinical Neurophysiology. He is considered an expert on Medicare reimbursement and CPT coding.

HOPE MAGO

A Principal of HCAP Partners, he led the HCAP Partners investment in CortiCare, Inc. in 2019. He earned an International MBA from the University of San Diego. He has led investment initiatives into several companies in the healthcare space. He is Deputy Chairman of Impact Capital Managers and an Advisory Board Member of Local Initiatives Support Corporation in San Diego.

PATRICIA CLOYD-SANTOS

Founder and Owner of Santos Neuro Care, LLC, she provides strategic planning and development in neuroscience acute care. Formerly the Executive Director, Neuroscience and Research at Cedars-Sinai Medical Center after holding similar positions at Providence Health and Services and Centura Health.

JANET DILLIONE

Experienced Executive Level Officer of a number of successful companies in the healthcare information services industry including, most recently, CEO of Bernoulli Enterprise, Inc. Previously holding executive positions at Nuance Communications and Siemens Medical Solutions. She serves on Boards for CorMedix, Inc. and Bernoulli Enterprise, Inc.


Advisory Board


DR. MARC NUWER, MD

Corporate Board Member, Chief, Clinical Neurophysiology UCLA, Neurology Professor. Graduated from Stanford School of Medicine. Past Board Member American Academy of Neurology (AAN) and President of the Int’l Federation of Clinical Neurophysiology. He is considered an expert on Medicare reimbursement and CPT coding.

DR. BRAD KOLLS, MD, PhD

Vice Chair of Informatics and Teleradiology with the Duke’s Dept. of Neurology. Medical Director of Duke’s Tele-stroke Network. Clinical and translational research focusing on brain monitoring in acute brain injury. MCCi – Masters in Management and Clinical Informatics.

DR. JON HALFORD, MD

Director of Clinical Trials for the Dept. of Neurology at Medical University of South Carolina (MUSC). He is Associate Director for Technical Development at the MUSC Clinical Neurophysiology Lab, where he helped develop an EEG Cloud Platform. He is also the Director of the Consortium Site at the Charleston VA Epilepsy Centers of Excellence.

DR. RICHARD HAAS, MD, PhD

Dr. Haas is a pediatric Neurologist serving both Rady’s and UCSD. He serves on the editorial board of the European Journal of Pediatric Neurology. He is the Principle Investigator for the Neolev drug dosage study for neonates, for which CortiCare provides monitoring to the 6 hospitals involved.

DR. JEFFREY GERTSCH

Professor and Medical Director of Interventional Neurophysiology Lab UCSD. Department of Neurosciences. WSET Medical Director.